MAIN LINE HEALTH CCOP
主线健康 CCOP
基本信息
- 批准号:7849068
- 负责人:
- 金额:$ 35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-08-05 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAreaArtsAwarenessCancer ControlCancer EtiologyCancer Prevention TrialCatchment AreaCessation of lifeClinical Research ProtocolsClinical TrialsColon CarcinomaCommunitiesCommunity Clinical Oncology ProgramCommunity ServicesCountyDelawareDoctor of MedicineEastern Cooperative Oncology GroupEducationElderlyFamily PracticeFoxesGene MutationGeneticGenetic CounselingGenetic ProgrammingGoalsGrantGynecologic Oncology GroupHealthHealth systemHereditary Malignant NeoplasmHospitalsIndividualKnowledgeMalignant NeoplasmsMinorityMissionNational Surgical Adjuvant Breast and Bowel ProjectOvarianPatientsPennsylvaniaPhiladelphiaPhysiciansPopulationPopulation HeterogeneityPreventionPrevention ProtocolsPrimary Health CarePrincipal InvestigatorProgress ReportsProtocols documentationPublic HealthRadiation Therapy Oncology GroupReapplicationRecording of previous eventsRegulatory AffairsReportingResearchResearch Ethics CommitteesRiskSchoolsScreening for cancerServicesSiblingsSilverStrategic PlanningStructureSystemTreatment ProtocolsUnited StatesUniversitiesWomanbasecancer carecancer geneticscancer preventionexperienceinnovationmalignant breast neoplasmoncologyoutreach programprogramssmoking cessationsymptom managementtreatment strategy
项目摘要
DESCRIPTION (provided by applicant): In this reapplication for the CCOP grant, we propose to maintain the Main Line Health CCOP as a consortium of oncology research programs between the 3 hospitals in the Main Line Health System: Lankenau Hospital, Bryn Mawr Hospital and Paoli Hospital. Our broad and long term objective is to provide access to and opportunity for participation in state-of-the-art cancer clinical trials and cancer prevention trials to the over 1.3 million people residing in the Main Line Health System community service area. This service area represents a diverse population including West Philadelphia, Montgomery and Delaware Counties and the fastest growing county in the United States, Chester County. Of the over 1.3 million residents in these counties, it is estimated that 15 % are over age 65. As part of these public health initiatives, our CCOP has partnered with the Main Line Health system's genetics programs to offer studies for cancer prevention to the public by providing genetic counseling and offering prevention trials to people with familial cancer histories. We currently have studies available for women at risk for ovarian and breast cancer and for siblings of patients with colon cancer. Our system wide smoking cessation trial and our outreach program have considerable impact on public health. Main Line Health has placed research and education among the top five strategic initiatives in the coming years. Our participation in large national clinical trials provide the opportunity to serve our community with options for cancer care by inclusion in research protocols to which they otherwise would not have had access. It is the mission of the oncology programs at Main Line Health to offer protocols that provide innovative treatment strategies as well as those that create approaches for cancer prevention and symptom management. Our alliance with the Fox Chase Research Base, M.D. Anderson Research Base, the Gynecologic Oncology Group, The Eastern Cooperative Oncology Group, the National Surgical Adjuvant Breast and Bowel Project, and the Radiation Therapy Oncology Group has allowed us to accomplish this.
描述(由申请人提供):在CCOP赠款的此重新申请中,我们建议将主线健康CCOP维持为主线卫生系统3家医院之间的肿瘤学研究计划的财团:Lankenau医院,Bryn Mawr医院和Paoli医院。我们的广泛和长期目标是为居住在主线卫生系统社区服务领域的130万人提供参与最先进的癌症临床试验和癌症预防试验的机会和机会。该服务地区代表了包括西费城,蒙哥马利和特拉华州县以及美国成长中最快的县,切斯特县的多样化人口。在这些县的130万居民中,据估计有15%的年龄超过65岁。作为这些公共卫生计划的一部分,我们的CCOP与主线卫生系统的遗传学计划合作,通过为家族癌症病人提供遗传咨询和提供预防试验,向公众提供预防癌症的研究。目前,我们有针对患有卵巢癌和乳腺癌风险的女性以及结肠癌患者的兄弟姐妹的研究。我们的系统广泛的戒烟试验和我们的外展计划对公共卫生有很大影响。在未来几年中,Main Line Health将研究和教育列入了前五名的战略计划。我们参与大型国家临床试验,为我们的社区提供了机会,可以通过纳入否则无法获得的研究方案来为癌症护理提供选择。正是Main Line Health的肿瘤学计划的使命是提供具有创新治疗策略的协议,以及为预防癌症预防和症状管理的方法提供的方案。我们与Fox Chase研究基础的联盟,医学博士Anderson研究基础,妇科肿瘤学小组,东部合作肿瘤学小组,国家手术辅助乳腺癌和肠项目以及放射治疗肿瘤学小组使我们能够完成此工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL B GILMAN其他文献
PAUL B GILMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL B GILMAN', 18)}}的其他基金
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
UNM FIRST: Promoting Inclusive Excellence in Neuroscience and Data Science
UNM FIRST:促进神经科学和数据科学领域的包容性卓越
- 批准号:
10493710 - 财政年份:2022
- 资助金额:
$ 35万 - 项目类别:
Core DResearch Experience Training Coordination (RETCC)
核心D研究经验培训协调(RETCC)
- 批准号:
10337085 - 财政年份:2020
- 资助金额:
$ 35万 - 项目类别:
Core DResearch Experience Training Coordination (RETCC)
核心D研究经验培训协调(RETCC)
- 批准号:
10560517 - 财政年份:2020
- 资助金额:
$ 35万 - 项目类别:
Strengthening Research and Sponsored Projects at Webster University (SRSP)
加强韦伯斯特大学的研究和赞助项目(SRSP)
- 批准号:
9918937 - 财政年份:2016
- 资助金额:
$ 35万 - 项目类别:
Strengthening Research and Sponsored Projects at Webster University (SRSP)
加强韦伯斯特大学的研究和赞助项目(SRSP)
- 批准号:
9270043 - 财政年份:2016
- 资助金额:
$ 35万 - 项目类别: